Epidemiology and health-related services

Pérez-Ruiz, Fernando; Urionagüena, Irati; Carmona, Loreto

doi:10.1097/bor.0000000000000258

Search citation statements

Order By: Relevance

Paper Sections

Select...

Increasing Research Efforts In Gout1

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 71 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One reason as outlined above has been the recognized rise in gout prevalence over the past decades and the poor outcomes experienced by patients with gout [2–4, 26–32]. A second motivation for research in the field was advances in the understanding of disease pathophysiology.…”

Section: Increasing Research Efforts In Goutmentioning

confidence: 99%

See 1 more Smart Citation

Gout Classification Criteria: Update and Implications

2016

View full text Add to dashboard Cite

Gout is the most common inflammatory arthritis, with a rising prevalence and incidence worldwide. There has been a resurgence in gout research, fueled, in part, by a number of advances in pharmacologic therapy for gout. The conduct of clinical trials and other observational research in gout requires a standardized and validated means of assembling well-defined groups of patients with gout for such research purposes. Recently, an international collaborative effort that involved a data-driven process with state-of-the art methodology supported by the American College of Rheumatology and the European League Against Rheumatism led to publication of new gout classification criteria.

show abstract

Section: Increasing Research Efforts In Goutmentioning

confidence: 99%

“…The increasing prevalence of the disease [2], along with evidence of poor outcomes in patients with gout [3, 4], has highlighted the need to improve gout management. To that end, four novel pharmacologic agents have been approved for the management of gout (i.e., hyperuricemia of gout or gout attacks) in the USA since 2009.…”

Section: Introductionmentioning

confidence: 99%